Cargando…
Inhibiting 5-hydroxytryptamine receptor 3 alleviates pathological changes of a mouse model of Alzheimer’s disease
[Image: see text] Extracellular amyloid beta (Aβ) plaques are main pathological feature of Alzheimer’s disease. However, the specific type of neurons that produce Aβ peptides in the initial stage of Alzheimer’s disease are unknown. In this study, we found that 5-hydroxytryptamin receptor 3A subunit...
Autores principales: | Liu, Li-Fen, Liu, Yu-Tong, Wu, Dan-Dan, Cheng, Jie, Li, Na-Na, Zheng, Ya-Ni, Huang, Liang, Yuan, Qiong-Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233771/ https://www.ncbi.nlm.nih.gov/pubmed/36926728 http://dx.doi.org/10.4103/1673-5374.366492 |
Ejemplares similares
-
Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model
por: Ding, Jiuyang, et al.
Publicado: (2021) -
Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer’s disease mouse model
por: Wu, Dan-Dan, et al.
Publicado: (2023) -
Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure
por: Chen, Yuting, et al.
Publicado: (2021) -
5- Hydroxytryptamine
por: Giarman, Nicholas J.
Publicado: (1958) -
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020)